Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20030105003A1
SERIAL NO

10115072

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, as well as diagnosing the presence or absence of antibodies related to increased or decreased risk of developing ischemic cardiovascular diseases, using one or more of said peptides in an ELISA (Enzyme Linked Immuno Sorbent Assay).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CARDIOVAX LLC2390 CRENSHAW BLVD SUITE 202 TORRANCE CA 90501

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nilsson, Jan Genarp, SE 107 721
Shah, Prediman K Los Angeles, CA 44 236

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation